Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Amoxicillin trihydrate 28.698 mg/mL equivalent to amoxycillin 25mg/mL; Potassium clavulanate 7.446 mg/mL equivalent to clavulanic acid 6.25mg/mL
GlaxoSmithKline NZ Limited
Amoxicillin trihydrate 28.698 mg/mL (=Amoxycillin 25 mg/mL)
125 mg/5mL
Powder for oral suspension
Active: Amoxicillin trihydrate 28.698 mg/mL equivalent to amoxycillin 25mg/mL Potassium clavulanate 7.446 mg/mL equivalent to clavulanic acid 6.25mg/mL Excipient: Aspartame Colloidal silicon dioxide Golden syrup flavour 52927 AP0551 Hydrated silica Hypromellose Orange flavour PHS-134215 Orange flavour SD653970 Raspberry flavour NN07943 Succinic acid Xanthan gum
Bottle, glass, Euro bottle, 100 mL
Prescription
Prescription
SmithKline Beecham Pharmaceuticals Ltd
AUGMENTIN should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data. AUGMENTIN is indicated for the short term treatment of common bacterial infections in adults and children such as: Upper Respiratory Tract Infections (including ENT): e.g. tonsillitis, sinusitis, otitis media Lower Respiratory Tract Infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho pneumonia Genito-urinary Tract Infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections Skin and Soft Tissue Infections Bone and Joint Infections: e.g. osteomyelitis Other Infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections Susceptibility to AUGMENTIN will vary with geography and time. Local susceptibility data should be consulted where available, and microbiological sampling and susceptibility testing performed where necessary. Infections caused by amoxicillin susceptible organisms are amenable to AUGMENTIN treatment due to its amoxicillin content. Mixed infections caused by amoxicillin susceptible organism in conjunction with AUGMENTIN susceptible beta-lactamase-producing organisms may therefore be treated by AUGMENTIN.
Package - Contents - Shelf Life: Bottle, glass, clear Ph Eur type III with CRC - 100 mL - 24 months from date of manufacture stored at or below 30°C 7 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
1983-11-22
AUGMENTIN 1 AUGMENTIN POWDER FOR ORAL SUSPENSION CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING AUGMENTIN? AUGMENTIN contains the active ingredient potassium clavulanate/amoxicillin trihydrate. AUGMENTIN is used for the short term treatment of infections in different parts of the body caused by bacteria. For more information, see Section 1. Why am I using AUGMENTIN? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE AUGMENTIN? Do not use if you have ever had an allergic reaction to AUGMENTIN or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use AUGMENTIN? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with AUGMENTIN and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE AUGMENTIN? • The usual dose may depend on the type of infection and how severe it is. More instructions can be found in Section 4. How do I use AUGMENTIN? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING AUGMENTIN? THINGS YOU SHOULD DO • Remind any doctor, dentist, pharmacist or nurse you visit that you are using AUGMENTIN. • Keep taking this medicine for the full time of treatment, even if you begin to feel better after a few days. THINGS YOU SHOULD NOT DO • Stop taking AUGMENTIN because you are feeling better, unless advised by your doctor. • Give AUGMENTIN to anyone else, even if they have the same condition as you. • Use AUGMENTIN to treat any other complaints unless your doctor tells you to. DRIVING OR USING MACHINES • AUGMENTIN does not usually affect the ability to drive or operate machinery. LOOKING AFTER YOUR MEDICINE • Keep the bottle ti Read the complete document
1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME AUGMENTIN 125 mg/31.25 mg powder for oral suspension AUGMENTIN FORTE 250 mg/62.5 mg powder for oral suspension AUGMENTIN 500 mg/125 mg film coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION AUGMENTIN powder for oral suspension: When reconstituted, each 5 mL contains amoxicillin trihydrate equivalent to 125 mg amoxicillin and potassium clavulanate equivalent to 31.25 mg clavulanic acid. AUGMENTIN FORTE powder for oral suspension: When reconstituted, each 5 mL contains amoxicillin trihydrate equivalent to 250 mg amoxicillin and potassium clavulanate equivalent to 62.5 mg clavulanic acid. AUGMENTIN tablets: Each film coated tablet contains amoxicillin trihydrate equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid. Excipients with known effect AUGMENTIN and AUGMENTIN FORTE powder for oral suspension: contains 2.5 mg of aspartame per mL. For the full list of excipients, see section 6.1 List of excipients. 3. PHARMACEUTICAL FORM AUGMENTIN: Powder for oral suspension. White to off-white powder. AUGMENTIN FORTE: Powder for oral suspension. White to off-white powder. AUGMENTIN tablets: White to off white, oval shaped, film coated tablets, approximately 20 mm x 9.5 mm, engraved 'AC' with a score line on one side and plain on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4.1 THERAPEUTIC INDICATIONS AUGMENTIN should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data. AUGMENTIN is indicated for the short term treatment of common bacterial infections in adults and children such as: UPPER RESPIRATORY TRACT INFECTIONS (INCLUDING ENT): e.g. tonsillitis, sinusitis, otitis media 2 LOWER RESPIRATORY TRACT INFECTIONS: e.g. acute exacerbation of chronic obstructive pulmonary disease (AECOPD)/acute exacerbations of chronic bronchitis (AECB), lobar and broncho-pneumonia GENITO-URINARY TRACT INFECTIONS: e.g. cystitis, Read the complete document